GCITekcapital's MicroSalt executes first bulk B2B order in US, continues expansion
( ) issued an update this morning on MicroSalt, the US operating subsidiary of Salarius, one of 's holdings, which announced today it had executed its first bulk B2B MicroSalt order in the US. The intellectual property investment group owns 97.2% of Salarius and 73% of MicroSalt.
Microsalt is an all-natural, non-GMO salt that contains approximately half the sodium content of regular table salt, using an advanced process that results in the same perceived taste at half the sodium content. The company aims to tackle the issue of excessive sodium consumption and related health issues, in a growing market for low-sodium products.
MicroSalt
Rick Guiney, MicroSalt CEO, commented: "This large initial order is a testament to the timeliness and flexibility of our products. Not only are we able to provide a low sodium solution at scale, but we also deliver a highly functional product that allows processors to eliminate several internal procedures. Interest is also very high for bulk B2B MicroSalt sales internationally."
MicroSalt's product is found in its own SaltMe brand of low-sodium potato chips, now available in over 3,000 retail stores in the US, up from 2,400 the previous quarter. SaltMe was also featured in a segment on healthy snacks aired on ABC News 4 Charleston in South Carolina, and is seeing significant growth in online sales and related social media engagements.
Successful marketing efforts resulted in MicroSalt's attendance at seven industry trade shows, and the company is now test marketing MicroSalt salt shakers for food service, dining establishments, or retail sale, with a further update on a wide roll-out to follow.
The company also raised the possibility of a potential future listing in London. Dr. Clifford Gross, Executive Chairman of said: "Based on the rapid progress of MicroSalt and the global opportunity to convert their patented, first-mover advantage into a potentially significant position in the low-sodium salt market, we are considering a listing of MicroSalt on the London market in 2023"
View from Vox
has been in the news over the last few months, updating markets on performance milestones. At the end of May, it raised $0.4m from a Spanish venture fund for MicroSalt having previously raised £2m to accelerate its portfolio growth a few days earlier.
Earlier in May, the company delivered its FY21 update. It said net assets had increased 108% to a record $68.1m, lifting NAV per share by 37%. It generated total income of $29.2m, up 243% YoY, while profit after tax increased 243% to $26.4m. Operating cash outflow of $1.8m was bolstered by share placings totalling $9.4m during the period, resulting in a robust balance sheet with cash and cash equivalents of $3.5m at the period end.
The rest of 's holdings, including Guident, Lucyd, and Belluscura, have all performed well. Click here and scroll down for summaries of their activities and recent performance. 's technology bets and ability to develop them have been rewarded by investors so far, and today's news sent the shares up a further 9.2%, giving a total gain of 32.5% over the last 12 months.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.